|
33
|
205
|
5fmgJ |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
62
|
234
|
5fgiH |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
66
|
231
|
5fg7E |
Yeast 20s proteasome beta2-t1a mutant |
|
64
|
231
|
5fgeE |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
69
|
244
|
5fggB |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
70
|
244
|
5fg9B |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
62
|
241
|
5fgdG |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
61
|
231
|
5fgiE |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
73
|
223
|
5fqaA |
Crystal structure of bacillus cereus metallo-beta-lactamase ii |
|
72
|
212
|
5fggK |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
70
|
240
|
5fgfC |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
62
|
195
|
5fgiJ |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
60
|
195
|
5fgaJ |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
60
|
195
|
5fgfJ |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
61
|
230
|
5fg9H |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
55
|
204
|
5fggI |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
67
|
244
|
5fgeB |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
70
|
243
|
5fgfF |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
64
|
231
|
5fhsE |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
61
|
195
|
5fghJ |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
66
|
233
|
5fgfM |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
68
|
250
|
5fgaA |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
71
|
215
|
5fgdK |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
68
|
250
|
5fgdA |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
69
|
242
|
5fghD |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
57
|
204
|
5fg7I |
Yeast 20s proteasome beta2-t1a mutant |
|
58
|
222
|
5fggH |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
44
|
236
|
5fmgN |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
70
|
244
|
5fghB |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
64
|
242
|
5fgdD |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
66
|
233
|
5fgeM |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
67
|
242
|
5fgiD |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
62
|
195
|
5fgeJ |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
68
|
243
|
5fg7F |
Yeast 20s proteasome beta2-t1a mutant |
|
67
|
242
|
5fgaD |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
62
|
231
|
5fghE |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
75
|
231
|
5fqcA |
Crystal structure of the metallo-beta-lactamase vim-2 with 2c |
|
68
|
242
|
5fg7D |
Yeast 20s proteasome beta2-t1a mutant |
|
69
|
250
|
5fgeA |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
40
|
226
|
5fmgB |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
63
|
241
|
5fghG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
67
|
249
|
5fgiA |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
71
|
243
|
5fhsF |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
43
|
230
|
5fmgE |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
67
|
250
|
5fg9A |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
65
|
242
|
5fhsD |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
69
|
243
|
5fg9F |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
70
|
212
|
5fgaK |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
62
|
196
|
5fgaN |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
62
|
196
|
5fgfN |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
